on INVENTIVA (EPA:IVA)
Inventiva announces its 2025 annual financial results
Biopharmaceutical company Inventiva today announced the release of its 2025 financial results. These results will be published on March 30, 2026, after the close of U.S. markets. Specializing in the development of an oral therapy for steatohepatitis associated with metabolic dysfunction, Inventiva will hold a conference call to discuss these results. This conference, scheduled for March 31, 2026, will be followed by a question-and-answer session. Connection information for this live event will be available to registered participants. A recording will be accessible on Inventiva's website.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INVENTIVA news